Medica S.p.A.

Equities

MDC

IT0005460149

Biotechnology & Medical Research

Market Closed - Borsa Italiana Other stock markets 11:44:59 2024-07-15 am EDT			5-day change	1st Jan Change
27.2 ^EUR	0.00%		+0.74%	+75.48%

07:10pm	Medica increases stake to 32 percent in Medico MedTech	AN
Apr. 29	Donaldson Agrees to Acquire 49% Stake in Medica	MT

Medica increases stake to 32 percent in Medico MedTech

July 15, 2024 at 01:10 pm EDT

(Alliance News) - Medica Spa announced Monday that it has increased its stake in Medico MedTech Co. Ltd, reaching 32 percent.

Medico MedTech is a trading company based in Suzhou, China, whose majority shareholder is Suzhou Huisheng Medical Science & Technology Co. Ltd.

The increase in shareholding is consequent to the fulfillment of a number of conditions in the previous agreement, allowing Medica to increase its stake from 20 percent to 32 percent of Medico MedTech's share capital.

Medica's stock closed Monday at par at EUR27.20 per share.

By Giuseppe Fabio Ciccomascolo, Alliance News senior reporter

Comments and questions to redazione@alliancenews.com

Go to the original article.
Legal disclaimer

Latest news about Medica S.p.A.

Medica increases stake to 32 percent in Medico MedTech	01:10pm	AN
Donaldson Agrees to Acquire 49% Stake in Medica	Apr. 29	MT
Response Plus Unit Closes Prometheus Medical Acquisition	Apr. 26	MT
ITALY GROWTH WINNERS & LOSERS: Medica bullish; Plants in the red.	Apr. 19	AN
Donaldson Company, Inc. made an offer to acquire Medica S.p.A. for ?22.9 million.	Apr. 18	CI
Substrate Artificial plans three AI-focused IPOs; eyes swing to profit	Apr. 11	AN
Medica S.p.A. Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 25	CI
Medica, profit falls in 2023 despite strong revenue growth	Mar. 25	AN
Mib advances; Leonardo and Ferrari on yearly highs	Mar. 25	AN
Futures down; new credit line for Pirelli	Mar. 25	AN
Mib up tepidly; sell-off on Webuild	Mar. 22	AN
India's Manipal Health set to buy majority stake in Medica Synergie for $151 million, source says	Mar. 14	RE
Beewize on sprint; Olidata down	Feb. 09	AN
Medica, FDA clears marketing of hemoconcentrators in U.S.	Feb. 08	AN
Olidata invests in digital healthcare by taking over 40 percent of Per Te	Feb. 06	AN
Medica closed 2023 with sharply increased revenues	Feb. 06	AN
Squares bullish; purchases on UniCredit and Azimut	Feb. 06	AN
Stock markets bullish; strong push on Asian stocks	Feb. 06	AN
UniCredit pushes Mib up, only bullish in Europe	Feb. 05	AN
CS Medica Obtains Danish Patent for Wound Healing Gel	Feb. 02	MT
CS Medica Set to Launch Pain Patch, Cosmetic Products in Australia	Jan. 26	MT
Medica strengthens in China, bought out 20 percent of China's Medico MedTech	Jan. 15	AN
Altamira Therapeutics Regains Compliance with Nasdaq's Minimum Stockholders Equity Requirement	Nov. 29	MT
Jiang Zhong Pharmaceutical to Buy Two Local Firms for 13.5 Million Yuan	Nov. 27	MT
Sector Update: Health Care Stocks Slipping Late Afternoon	Nov. 17	MT

Chart Medica S.p.A.

Duration

Period

More charts

Company Profile

Medica SpA is an Italy-based company primarily engaged in designing, manufacturing and supplying blood purification systems. Through subsidiaries, such as Tecnoideal sel the Company not only offers dialyzers, ultrafilters, HDF online sets, bloodlines, and pediatric dialyzers for dialysis treatment but also provides critical care CRRT equipment, hemofilter, pediatric filters, C02 removal, apheresis equipment, fractionator-cascade filtration, plasma filters, and leukocyte adsorber. It also supplies Cardiosmart, an integrated system for the treatment of patients affected by congestive heart failure; MediSulfone membrane and Purema hemoconcentration. It is engaged in water purification offering systems, including lab-pharma-industrial filtrations, individual water purifiers, and point-of-use filtrations. The Company provides infusion sets, urodynamic systems, palm bladder scanner and gastroenterology systems, among others. It operates globally.

Sector

Biotechnology & Medical Research

More about the company

Income Statement Evolution

More financial data

Ratings for Medica S.p.A.

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

27.2 EUR

Average target price

31.4 EUR

Spread / Average Target

+15.44%

Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

	1st Jan change	Capi.
MEDICA S.P.A.	+75.48%	125M
MODERNA, INC.	+22.15%	46.55B
LONZA GROUP AG	+45.94%	41.84B
IQVIA HOLDINGS INC.	-2.37%	40.84B
ALNYLAM PHARMACEUTICALS, INC.	+33.84%	32.95B
CELLTRION, INC.	-6.35%	28.27B
ICON PUBLIC LIMITED COMPANY	+20.42%	27.78B
UNITED THERAPEUTICS CORPORATION	+48.83%	14.26B
MEDPACE HOLDINGS, INC.	+45.00%	13.69B
BIO-TECHNE CORPORATION	+0.06%	12.18B

Other Biotechnology & Medical Research